Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma

P. Eleuteri, M. G. Grollino, D. Pomponi, R. De Vita

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To investigate the role of the monosomy 9 in bladder carcinogenesis, 96 cases of superficial bladder transitional cell carcinoma (TCC) were studied and followed periodically for around 3 years (mean±standard error of the mean (SEM); 3.46±0.34 years). Samples from bladder washings were analysed by fluorescent in situ hybridisation (FISH) to detect numerical anomalies of chromosome 9. Moreover, to evaluate the relative underrepresentation of this chromosome, we detected numerical changes of chromosome 8 and DNA ploidy by flow cytometric analysis (FCM). Chromosome 8 copy number were related to FCM DNA ploidy and both were related with tumour grade. Monosomy 9 did not correlate with tumour grade, stage, chromosome 8 aneuploidies and abnormal DNA content, but correlated with tumour progression. Comparing the results in the primary and subsequent tumours, we observed an increase in the frequency of aneuploidies by FCM, associated with an increase of chromosome 8 polysomies. The mean chromosome 9 copy number/nucleus remained nearly the same in most of the primary and invasive tumours. Our results confirm that monosomy 9 is an early event and that it is retained during tumour progression and invasion and that the loss occurs before the tetraploidisation process. The relationship between the presence of a sub-population with monosomy 9 and tumour progression suggests the presence of a region that could have a role in the progression of superficial bladder TCC.

Original languageEnglish
Pages (from-to)1496-1503
Number of pages8
JournalEuropean Journal of Cancer
Volume37
Issue number12
DOIs
Publication statusPublished - 2001

Fingerprint

Chromosomes, Human, Pair 9
Transitional Cell Carcinoma
Fluorescence In Situ Hybridization
Chromosome Aberrations
Urinary Bladder
Monosomy
Chromosomes, Human, Pair 8
Neoplasms
Ploidies
Aneuploidy
DNA
Carcinogenesis
Chromosomes
Population

Keywords

  • Chromosome 8
  • DNA ploidy
  • Monosomy 9
  • Tumour progression

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. / Eleuteri, P.; Grollino, M. G.; Pomponi, D.; De Vita, R.

In: European Journal of Cancer, Vol. 37, No. 12, 2001, p. 1496-1503.

Research output: Contribution to journalArticle

Eleuteri, P. ; Grollino, M. G. ; Pomponi, D. ; De Vita, R. / Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. In: European Journal of Cancer. 2001 ; Vol. 37, No. 12. pp. 1496-1503.
@article{c67f39d90c4d44958c3d7444f921e4a1,
title = "Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma",
abstract = "To investigate the role of the monosomy 9 in bladder carcinogenesis, 96 cases of superficial bladder transitional cell carcinoma (TCC) were studied and followed periodically for around 3 years (mean±standard error of the mean (SEM); 3.46±0.34 years). Samples from bladder washings were analysed by fluorescent in situ hybridisation (FISH) to detect numerical anomalies of chromosome 9. Moreover, to evaluate the relative underrepresentation of this chromosome, we detected numerical changes of chromosome 8 and DNA ploidy by flow cytometric analysis (FCM). Chromosome 8 copy number were related to FCM DNA ploidy and both were related with tumour grade. Monosomy 9 did not correlate with tumour grade, stage, chromosome 8 aneuploidies and abnormal DNA content, but correlated with tumour progression. Comparing the results in the primary and subsequent tumours, we observed an increase in the frequency of aneuploidies by FCM, associated with an increase of chromosome 8 polysomies. The mean chromosome 9 copy number/nucleus remained nearly the same in most of the primary and invasive tumours. Our results confirm that monosomy 9 is an early event and that it is retained during tumour progression and invasion and that the loss occurs before the tetraploidisation process. The relationship between the presence of a sub-population with monosomy 9 and tumour progression suggests the presence of a region that could have a role in the progression of superficial bladder TCC.",
keywords = "Chromosome 8, DNA ploidy, Monosomy 9, Tumour progression",
author = "P. Eleuteri and Grollino, {M. G.} and D. Pomponi and {De Vita}, R.",
year = "2001",
doi = "10.1016/S0959-8049(01)00151-4",
language = "English",
volume = "37",
pages = "1496--1503",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "12",

}

TY - JOUR

T1 - Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma

AU - Eleuteri, P.

AU - Grollino, M. G.

AU - Pomponi, D.

AU - De Vita, R.

PY - 2001

Y1 - 2001

N2 - To investigate the role of the monosomy 9 in bladder carcinogenesis, 96 cases of superficial bladder transitional cell carcinoma (TCC) were studied and followed periodically for around 3 years (mean±standard error of the mean (SEM); 3.46±0.34 years). Samples from bladder washings were analysed by fluorescent in situ hybridisation (FISH) to detect numerical anomalies of chromosome 9. Moreover, to evaluate the relative underrepresentation of this chromosome, we detected numerical changes of chromosome 8 and DNA ploidy by flow cytometric analysis (FCM). Chromosome 8 copy number were related to FCM DNA ploidy and both were related with tumour grade. Monosomy 9 did not correlate with tumour grade, stage, chromosome 8 aneuploidies and abnormal DNA content, but correlated with tumour progression. Comparing the results in the primary and subsequent tumours, we observed an increase in the frequency of aneuploidies by FCM, associated with an increase of chromosome 8 polysomies. The mean chromosome 9 copy number/nucleus remained nearly the same in most of the primary and invasive tumours. Our results confirm that monosomy 9 is an early event and that it is retained during tumour progression and invasion and that the loss occurs before the tetraploidisation process. The relationship between the presence of a sub-population with monosomy 9 and tumour progression suggests the presence of a region that could have a role in the progression of superficial bladder TCC.

AB - To investigate the role of the monosomy 9 in bladder carcinogenesis, 96 cases of superficial bladder transitional cell carcinoma (TCC) were studied and followed periodically for around 3 years (mean±standard error of the mean (SEM); 3.46±0.34 years). Samples from bladder washings were analysed by fluorescent in situ hybridisation (FISH) to detect numerical anomalies of chromosome 9. Moreover, to evaluate the relative underrepresentation of this chromosome, we detected numerical changes of chromosome 8 and DNA ploidy by flow cytometric analysis (FCM). Chromosome 8 copy number were related to FCM DNA ploidy and both were related with tumour grade. Monosomy 9 did not correlate with tumour grade, stage, chromosome 8 aneuploidies and abnormal DNA content, but correlated with tumour progression. Comparing the results in the primary and subsequent tumours, we observed an increase in the frequency of aneuploidies by FCM, associated with an increase of chromosome 8 polysomies. The mean chromosome 9 copy number/nucleus remained nearly the same in most of the primary and invasive tumours. Our results confirm that monosomy 9 is an early event and that it is retained during tumour progression and invasion and that the loss occurs before the tetraploidisation process. The relationship between the presence of a sub-population with monosomy 9 and tumour progression suggests the presence of a region that could have a role in the progression of superficial bladder TCC.

KW - Chromosome 8

KW - DNA ploidy

KW - Monosomy 9

KW - Tumour progression

UR - http://www.scopus.com/inward/record.url?scp=0034889415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034889415&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(01)00151-4

DO - 10.1016/S0959-8049(01)00151-4

M3 - Article

VL - 37

SP - 1496

EP - 1503

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 12

ER -